Other News

CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review

PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that it has received the recommendation from the independent Data and Safety Monitoring Board […]

CardieX Selected for Medtech Innovator’s 2023 Accelerator Cohort

IRVIVE, Calif., June 14, 2023 /PRNewswire/ — Cardiovascular health technology company, CardieX Limited, is pleased to announce it has been selected as part of MedTech Innovator’s 2023 Accelerator Cohort. MedTech Innovator is recognized as the world’s largest accelerator of medical technology companies. More than 1,150 companies applied to participate in the 2023 Accelerator program […]

Philips’ direct-to-angio stroke pathway: new analysis demonstrates substantial cost savings in addition to improved patient outcomes

Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional […]

Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System

Addition to Pounce™ thrombectomy platform with the low-profile (LP) model will allow for efficient clot removal in below-the-knee peripheral arteries (2 mm to 4 mm), expanding the addressable market for the Pounce™ platform EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic […]

Imperative Care Announces Three Senior Leadership Appointments for Kandu Health

Kirsten Carroll appointed CEO; Stefan Heuser named CFO and Clayton Duncan named SVP, Commercialization Kandu Health achieves successful enrollment of the first 50 stroke survivors in its stroke recovery program CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases, […]

Dr. Jonathan Weinsaft Named Chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

NEW YORK (June 14, 2023)— Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1. The Greenberg Division of Cardiology, housed within the Weill […]

PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial

Novel Polymeric Valve Aims to Reduce Re-operations and Re-interventions PITTSBURGH–(BUSINESS WIRE)–PECA Labs, a medical device company reimagining vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, today announced the successful first-in-human implant of the MASA Valve. Designed for pediatrics, the MASA Valve is a […]

DEEPER OUS Trial Evaluating Reflow Medical’s Bare Temporary Spur Stent System Shows Positive Results at Six Months

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announced the six-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System. Results were presented at the annual Leipzig International Course (LINC) in Leipzig, Germany. Michael Lichtenberg, MD, FESC, Chief Medical Officer and […]

GORE INITIATES STUDY TO COMPARE THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS TO BARE METAL STENTS

The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease. FLAGSTAFF, Ariz., June 13, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) announced today the initiation of the Gore VBX FORWARD Clinical Study (NCT05811364) […]